Circulating endothelial‐coagulative activation markers after smoking cessation: a 12‐month observational study
- 29 December 2010
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 41 (6) , 616-626
Abstract
Eur J Clin Invest 2011; 41 (6): 616–626 Background Cigarette smoking is associated with cardiovascular morbidity and mortality. Exposure to cigarette smoke can cause endothelial dysfunction with impaired endothelium‐dependent vasodilation and ‘endothelial activation’, which predispose to atherothrombosis. The effects of continued smoking and smoking cessation on the level of endothelial, platelet and clotting activation have not been described previously. Here, we prospectively monitored changes in circulating endothelial‐coagulative activation markers in smokers undertaking smoking cessation.Method This 12‐month prospective study of 174 smokers with no commonly acquired atherothrombotic risk factors underwent an intensive smoking‐cessation programme investigating the effect of quitting on circulating levels of von Willebrand’s Factor Antigen (vWF:Ag), soluble Thrombomodulin (sTM), d‐Dimer (d‐D), prothrombin fragment F1 + 2 (F1 + 2), platelet factor‐4 (PF4) and β‐Thromboglobulin (β‐TG). Blood samples and study measures were collected and compared at baseline and at 2, 6 and 12 months after smoking cessation from quitters and relapsers’.Results No significant differences in demographic or laboratory parameters at baseline were observed between the study groups. Significant changes in von Willebrand’s Factor activity were observed at 2 months after smoking cessation, with levels decreasing from 141·8% to 113·6%. Substantial modifications in d‐Dimer, prothrombin fragment F1 + 2, platelet factor‐4 and β‐thromboglobulin concentrations were observed only at 6 and 12 months after smoking cessation. Positive associations between baseline levels of these biomarkers and number of pack per years have been demonstrated.Conclusions Chronic exposure to cigarette smoke sustains the activation of the endothelial‐coagulative system and abstinence may result in the improvement of several endothelial‐coagulative abnormalities in regular smokers. This may translate into an overall decline in cardiovascular risk.Keywords
This publication has 56 references indexed in Scilit:
- Therapeutic advances in the treatment of nicotine addiction: present and futureTherapeutic Advances in Chronic Disease, 2010
- A catalogue of reporting guidelines for health researchEuropean Journal of Clinical Investigation, 2009
- Effects of smoking cessation on coronary endothelial function in patients with recent myocardial infarctionInternational Journal of Cardiology, 2008
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationPLOS Medicine, 2007
- The Influence of Smoking Cessation on Hemodynamics and Arterial ComplianceAngiology, 2006
- Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trialEuropean Journal of Preventive Cardiology, 2005
- Acute effects of cigarette smoking on platelet-dependent thrombin generationEuropean Heart Journal, 2001
- Current Smokers Develop More Posterior Myocardial Infarctions Probably Due to Increased Tendency to ThrombosisScandinavian Cardiovascular Journal, 2000
- Acute myocardial infarction: association with time since stopping smoking in Italy. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto. Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico.Journal of Epidemiology and Community Health, 1994
- Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1980